Pharmaceutical Biotechnology

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2024-2025

Lehrbeauftragte/r

  • Pongrácz Judit Erzsébet

    professor,
    Faculty of Health Sciences - Institute of Health Science, Department of Public Health

Semesterwochenstunden

Vorlesungen: 28

Praktika: 14

Seminare: 14

Insgesamt: 56

Fachangaben

  • Kode des Kurses: OBA-115-T
  • 4 kredit
  • Biotechnology MSc
  • Basic modul
  • spring
Voraussetzungen:

OBA-128-T parallel

Zahl der Kursteilnehmer für den Kurs:

min. 1 – max. 50

Thematik

Pharmaceutical biotechnology

Vorlesungen

  • 1. Pharmaceuticals, biologics and biopharmaceuticals - Pongrácz Judit Erzsébet
  • 2. Plant biotechnology II. - Pongrácz Judit Erzsébet
  • 3. Cancer drugs using anti-cancer plant metabolites I. - Pongrácz Judit Erzsébet
  • 4. Cancer drugs using anti-cancer plant metabolites II. - Pongrácz Judit Erzsébet
  • 5. Cancer drugs - a different approach: appearance of monoclonal antibodies I. - Pongrácz Judit Erzsébet
  • 6. Cancer drugs - a different approach: monoclonal antibodies II. - Pongrácz Judit Erzsébet
  • 7. Cancer drugs - CAR-T cell therapy I. - Pongrácz Judit Erzsébet
  • 8. Cancer drugs - CAR-T cell therapy II. - Pongrácz Judit Erzsébet
  • 9. Drug development against viruses - the role of biotechnology I. - Pongrácz Judit Erzsébet
  • 10. Drug development against viruses - the role of biotechnology II. - Pongrácz Judit Erzsébet
  • 11. Drug development and biotechnology against bacterial infections I. - Pongrácz Judit Erzsébet
  • 12. Drug development and biotechnology against bacterial infections II. - Pongrácz Judit Erzsébet
  • 13. Mid-term test - Pongrácz Judit Erzsébet
  • 14. Mid-term test - Pongrácz Judit Erzsébet
  • 15. Cytokines and other simple peptides and proteins – the easiest task for pharmaceutical biotechnologiests? I. - Pongrácz Judit Erzsébet
  • 16. Cytokines and other simple peptides and proteins – the easiest task for pharmaceutical biotechnologiests? II. - Pongrácz Judit Erzsébet
  • 17. (L)ADMETOX I. - Pongrácz Judit Erzsébet
  • 18. (L)ADMETOX II. - Pongrácz Judit Erzsébet
  • 19. Factors influencing drug response I. - Pongrácz Judit Erzsébet
  • 20. Factors influencing drug response II. - Pongrácz Judit Erzsébet
  • 21. Molecular drug transport I. - Pongrácz Judit Erzsébet
  • 22. Molecular drug transport II. - Pongrácz Judit Erzsébet
  • 23. Influencing drug transporters I. - Pongrácz Judit Erzsébet
  • 24. Influencing drug transporters II. - Pongrácz Judit Erzsébet
  • 25. Test systems for toxicology I. - Pongrácz Judit Erzsébet
  • 26. Test systems for toxicology II. - Pongrácz Judit Erzsébet
  • 27. Test systems for drug efficacy I. - Pongrácz Judit Erzsébet
  • 28. Test systems for drug efficacy II. - Pongrácz Judit Erzsébet

Praktika

  • 1. Principals of gene cloning - using the NCBI database
  • 2. Cloning a specific gene - a practical approach 1
  • 3. Cloning a specific gene - a practical approach 2
  • 4. Cloning a specific gene - a practical approach 3
  • 5. Culturing organisms for protein production
  • 6. Culturing organisms for protein production
  • 7. Selection and application of organisms for protein production
  • 8. Protein purification for therapeutic application 1
  • 9. Protein purification for therapeutic application 2
  • 10. Technical approach for monoclonal antibody production 1
  • 11. Technical approach for monoclonal antibody production 2
  • 12. Testing toxicity using methodology of biotechnology
  • 13. Efficacy testing using methodology of biotechnology
  • 14. Nanotechnological methods

Seminare

  • 1. Pharmaceuticals, biologics and biopharmaceuticals - Pongrácz Judit Erzsébet
  • 2. Cancer drugs using anti-cancer plant metabolites I. - Pongrácz Judit Erzsébet
  • 3. Cancer drugs - a different approach: appearance of monoclonal antibodies I. - Pongrácz Judit Erzsébet
  • 4. Cancer drugs - CAR-T cell therapy I. - Pongrácz Judit Erzsébet
  • 5. Drug development against viruses - the role of biotechnology I. - Pongrácz Judit Erzsébet
  • 6. Drug development and biotechnology against bacterial infections I. - Pongrácz Judit Erzsébet
  • 7. Mid-term test - Pongrácz Judit Erzsébet
  • 8. Cytokines and other simple peptides and proteins – the easiest task for pharmaceutical biotechnologiests? I. - Pongrácz Judit Erzsébet
  • 9. (L)ADMETOX I. - Pongrácz Judit Erzsébet
  • 10. Factors influencing drug response I. - Pongrácz Judit Erzsébet
  • 11. Molecular drug transport I. - Pongrácz Judit Erzsébet
  • 12. Influencing drug transporters I. - Pongrácz Judit Erzsébet
  • 13. Test systems for toxicology I. - Pongrácz Judit Erzsébet
  • 14. Test systems for drug efficacy I. - Pongrácz Judit Erzsébet

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

Vom Institut veröffentlichter Lehrstoff

Lecture ppt

Skript

Empfohlene Literatur

Pharmaceutical biotechnology, Ed: Gary Walsh, Wiley

Voraussetzung zum Absolvieren des Semesters

Attendance to 75% of lectures and practices

Semesteranforderungen

Written test

Möglichkeiten zur Nachholung der Fehlzeiten

None

Prüfungsfragen

meetstreet, Teams, Moodle

Prüfer

  • Pongrácz Judit Erzsébet

Praktika, Seminarleiter/innen

  • Papp Alexandra
  • Steinerbrunnerné Nagy Alexandra